Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  NVIDIA Corporation    NVDA

NVIDIA CORPORATION

(NVDA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

NVIDIA : MONAI Imaging Framework Fast-Tracked to Production to Accelerate AI in Healthcare

11/30/2020 | 09:36am EST

MONAI - the Medical Open Network for AI, a domain-optimized, open-source framework for healthcare - is now ready for production with the upcoming release of the NVIDIA Clara application framework for AI-powered healthcare and life sciences.

Introduced in April and already adopted by leading healthcare research institutions, MONAI is a PyTorch-based framework that enables the development of AI for medical imaging with industry-specific data handling, high-performance training workflows and reproducible reference implementations of state-of-the-art approaches.

As part of the updated Clara offering, MONAI will come with over 20 pre-trained models, including ones recently developed for COVID-19, as well as the latest training optimizations on NVIDIA DGX A100 GPUs that provide up to a sixfold acceleration in training turnaround time.

'MONAI is becoming the PyTorch of healthcare, paving the way for closer collaboration between data scientists and clinicians,' said Dr. Jayashree Kalpathy-Cramer, director of the QTIM lab at the Athinoula A. Martinos Center for Biomedical Imaging at MGH. 'Global adoption of MONAI is fostering collaboration across the globe facilitated by federated learning.'

Adoption by the healthcare ecosystem of MONAI has been tremendous. DKFZ, King's College London, Mass General, Stanford and Vanderbilt are among those to adopt the AI framework for imaging. MONAI is being used in everything from industry-leading imaging competitions to the first boot camp focused on the framework, held in September, which drew over 550 registrants from 40 countries, including undergraduate university students.

'MONAI is quickly becoming the go-to deep learning framework for healthcare. Getting from research to production is critical for the integration of AI applications into clinical care,' said Dr. Bennett Landman of Vanderbilt University. 'NVIDIA's commitment to community-driven science and allowing the academic community to contribute to a framework that is production-ready will allow for further innovation to build enterprise-ready features.'

New Features

NVIDIA Clara brings the latest breakthroughs in AI-assisted annotation, federated learning and production deployment to the MONAI community.

The latest version introduces a game-changer to AI-assisted annotation that allows radiologists to label complex 3D CT data in one-tenth of the clicks with a new model called DeepGrow 3D. Instead of the traditional time-consuming method of segmenting an organ or lesion image by image or slice by slice, which can be up to 250 clicks for a large organ like the liver, users can segment with far fewer clicks.

Integrated with Fovia Ai's F.A.S.T. AI Annotation software, NVIDIA Clara's AI-assisted annotation tools and the new DeepGrow 3D feature can be used for labeling training data as well as assisting radiologists when reading. Fovia offers the XStream HDVR SDK suite to review DICOM images that's integrated into industry-leading PACS viewers.

AI-assisted annotation is the key to unlocking rich radiology datasets and was recently used to label the public COVID-19 CT dataset published by The Cancer Imaging Archive at the U.S. National Institutes of Health. This labeled dataset was then used in the MICCAI-endorsed COVID-19 Lung CT Lesion Segmentation Challenge.

Clara Federated Learning made possible the recent research collaboration of 20 hospitals around the world to develop a generalized AI model for COVID-19 patients. The EXAM model predicts oxygen requirements in COVID-19 patients, is available on the NGC software registry, and is being evaluated for clinical validation at Mount Sinai Health System in New York, Diagnósticos da America SA in Brazil, NIHR Cambridge Biomedical Research Centre in the U.K. and the NIH.

'The MONAI software framework provides key components for training and evaluating imaging-based deep learning models, and its open-source approach is fostering a growing community that is contributing exciting advances, such as federated learning,' said Dr. Daniel Rubin, professor of biomedical data science, radiology and medicine at Stanford University.

NVIDIA is additionally expanding its release of NVIDIA Clara to digital pathology applications, where the sheer sizes of images would choke off-the-shelf open-source AI tools. Clara for pathology early access contains reference pipelines for both training and deployment of AI applications.

'Healthcare data interoperability, model deployment and clinical pathway integration are an increasingly complex and intertwined topic, with significant field-specific expertise,' said Jorge Cardoso, CTO of the London Medical Imaging and AI Centre for Value-based Healthcare. 'Project MONAI, jointly with the rest of the NVIDIA Clara ecosystem, will help deliver improvements to patient care and optimize hospital operations.'

Learn more about NVIDIA Clara Train 4.0 and subscribe to NVIDIA healthcare news.

Disclaimer

Nvidia Corporation published this content on 30 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 November 2020 14:36:01 UTC


© Publicnow 2020
All news about NVIDIA CORPORATION
01/19A TRUSTED COMPANION : AI Software Keeps Drivers Safe and Focused on the Road Ahe..
PU
01/19How Volkswagen's $50 Billion Plan to Beat Tesla Short-Circuited
DJ
01/19Stock Futures Rise as Earnings Season Ramps Up
DJ
01/19Chinese regulator approves Cisco's $4.5 bln Acacia deal
RE
01/15ELECTRIC AVENUE : NVIDIA Engineer Revs Up Classic Car to Sport AI
PU
01/15NVIDIA : Susquehanna Lifts NVIDIA's Price Target to $625 From $610, Maintains Po..
MT
01/15NVIDIA : Truist Hikes NVIDIA's Price Target to $672 From $643, Maintains Buy Rat..
MT
01/14NVIDIA : Amid CES, NVIDIA Packs Flying, Driving, Gaming Tech News into a Single ..
PU
01/14IM AI : China Automaker SAIC Unveils EV Brand Powered by NVIDIA DRIVE Orin
PU
01/14E-Commerce Titan Alibaba Links with SAIC Motor in Battery-Car JV
MT
More news
Financials (USD)
Sales 2021 16 461 M - -
Net income 2021 4 079 M - -
Net cash 2021 4 776 M - -
P/E ratio 2021 80,7x
Yield 2021 0,12%
Capitalization 331 B 331 B -
EV / Sales 2021 19,8x
EV / Sales 2022 16,3x
Nbr of Employees 13 775
Free-Float 61,7%
Chart NVIDIA CORPORATION
Duration : Period :
NVIDIA Corporation Technical Analysis Chart | NVDA | US67066G1040 | MarketScreener
Technical analysis trends NVIDIA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 41
Average target price 587,15 $
Last Close Price 534,63 $
Spread / Highest target 30,9%
Spread / Average Target 9,82%
Spread / Lowest Target -36,4%
EPS Revisions
Managers and Directors
NameTitle
Jen-Hsun Huang President, Chief Executive Officer & Director
Debora Shoquist Executive Vice President-Operations
Colette M. Kress Chief Financial Officer & Executive Vice President
William James Dally Chief Scientist & Senior Vice President-Research
Tony Tamasi Senior Vice President-Content & Technology
Sector and Competitors
1st jan.Capitalization (M$)
NVIDIA CORPORATION2.38%330 936
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED22.08%580 386
INTEL CORPORATION16.40%237 643
BROADCOM INC.5.49%186 791
QUALCOMM INCORPORATED7.50%185 224
TEXAS INSTRUMENTS5.61%159 896